Parsons James T.
Insider CIK 1759855 · ONCY Director · DMAC Director · TRIL Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ONCY ONCOLYTICS BIOTECH INC | A Award deriv | 2026-06-01 | 2026-06-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award deriv | 2026-06-01 | 2026-06-03 | 51,189 | — | $0 | 51,189 | SEC↗ |
| ONCY ONCOLYTICS BIOTECH INC | P Buy | 2026-03-11 | 2026-03-13 | 10,000 | $1.03 | $10.3K | 41,849 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award | 2026-01-02 | 2026-01-06 | 10,095 | $8.42 | $85.0K | 97,949 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | M Exercise deriv | 2025-11-21 | 2025-11-25 | 12,000 | — | $0 | 0 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | M Exercise | 2025-11-21 | 2025-11-25 | 12,000 | $2.20 | $26.4K | 87,854 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award deriv | 2025-06-01 | 2025-06-03 | 40,739 | — | $0 | 40,739 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award deriv | 2025-01-02 | 2025-01-03 | 4,287 | — | $0 | 4,287 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award | 2025-01-02 | 2025-01-03 | 15,917 | $5.34 | $85.0K | 75,854 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award deriv | 2024-06-01 | 2024-06-03 | 28,472 | — | $0 | 28,472 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award | 2024-01-02 | 2024-01-02 | 21,428 | $2.80 | $60.0K | 59,937 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award deriv | 2023-06-01 | 2023-06-02 | 16,968 | — | $0 | 16,968 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award deriv | 2022-06-01 | 2022-06-02 | 13,222 | — | $0 | 13,222 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award | 2022-01-03 | 2022-01-03 | 16,773 | $3.58 | $60.0K | 38,509 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 94,792 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 180,000 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 59,896 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 5,761 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 36,204 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 24,390 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 30,171 | — | $0 | 0 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 30,171 | — | $0 | 0 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award deriv | 2021-07-15 | 2021-07-16 | 9,393 | — | $0 | 9,393 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise deriv | 2021-01-08 | 2021-01-12 | 8,505 | — | $0 | 5,761 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | M Exercise | 2021-01-08 | 2021-01-12 | 8,505 | $7.24 | $61.6K | 8,505 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | S Sale | 2021-01-08 | 2021-01-12 | 8,505 | $15.79 | $134.3K | 0 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award | 2021-01-01 | 2021-01-04 | 7,745 | $8.23 | $63.7K | 21,947 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award deriv | 2020-06-01 | 2020-06-02 | 13,306 | — | $0 | 13,306 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award | 2020-06-01 | 2020-06-02 | 8,102 | $4.59 | $37.2K | 14,202 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | A Award deriv | 2019-06-24 | 2019-06-26 | 12,950 | — | $0 | 12,950 | SEC↗ |
| DMAC DiaMedica Therapeutics Inc | P Buy | 2018-12-11 | 2018-12-11 | 2,250 | $4.00 | $9.0K | 6,100 | SEC↗ |